LONDON–(BUSINESS WIRE)–Gyroscope Therapeutics Appoints Jessica Stitt as Chief Financial Officer.
Category: News
Keratoconus Progression Measurements Often Miss the Target
Dr Christopher Rapuano comments on a recent study showing significant measurement variability of the Pentacam, and what it may mean for treating progression. Medscape Ophthalmology
Microfluidics and AI Microscopy for Hemoglobin Measurements
Researchers at the Indian Institute of Science and SigTuple Technologies, a company based in Bengaluru, India, have developed a method to inexpensively measure hemoglobin levels in small-volume blood samples. The technique combines a microfluidic chip and an AI-powered microscope. The researchers hope that the technology will help streamline hemogl (Read more...)
How Do We Protect Science From the Next Trump?
To prevent future political interference in science, agencies must build a lasting culture of scientific integrity. Undark
Ocular Therapeutix™ To Report Fourth Quarter and Year End 2020 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Iveric Bio to Present at the Cowen 41st Annual Health Care Conference
NEW YORK–(BUSINESS WIRE)–Iveric Bio announced that Glenn Sblendorio, CEO, and Pravin Dugel, CSO, CBO, will participate in a fireside chat at the Cowen Conference on March 4.
Takeda Fornece Atualizações sobre Testes Clínicos da Fase 1/2 de Candidatos à Vacina para COVID-19 da Novavax e Moderna no Japão
OSAKA, Japão–(BUSINESS WIRE)–A Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) anunciou hoje que o primeiro indivíduo foi dosado na fase 1/2 do estudo de imunogenicidade e segurança da vacina candidata para COVID-19 da Novavax (TAK-019) no …
Takeda proporciona información actualizada sobre los ensayos clínicos de fase 1/2 de las candidatas a vacunas contra la COVID-19 de Novavax y Moderna en Japón
OSAKA, Japón–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ha anunciado hoy la administración de la primera dosis en su estudio de inmunogenicidad y seguridad de fase 1/2 de la vacuna candidata contra la COVID-19 de Novava…
Takeda présente des mises à jour sur les essais cliniques de Phase 1/2 portant sur les candidats vaccins contre la COVID-19 de Novavax et Moderna au Japon
OSAKA, Japon–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) annonce aujourd’hui le dosage du premier patient dans son étude de Phase 1/2 portant sur l’immunogénicité et l’innocuité du vaccin candidat contre la COVID-19 de N…
Takeda informiert über den aktuellen Stand der klinischen Phase 1/2-Studien mit den COVID-19-Impfstoffkandidaten von Novavax und Moderna in Japan
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) gab heute bekannt, dass der erste Proband im Rahmen der Phase-1/2-Studie zu Sicherheit und Immunogenität des COVID-19-Impfstoffkandidaten (TAK-019) von Novavax in …
Riassunto: Takeda fornisce aggiornamenti sugli studi clinici di fase 1/2 dei candidati vaccini anti COVID-19 di Novavax e Moderna in Giappone
OSAKA, Giappone–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) oggi ha annunciato l’inoculazione del primo soggetto dello studio di fase 1/2 su immunogenicità e sicurezza del candidato vaccino anti COVID-19 di Novavax (TAK-…
Intraoral Stimulation for Obstructive Sleep Apnea: Interview with Akhil Tripathi, CEO of Signifier Medical
Signifier Medical Technologies, a company with headquarters in London, UK and Massachusetts, has created a new treatment for obstructive sleep apnea, and it is the first to be used during waking hours. Unlike conventional sleep apnea devices, the eXciteOSA is designed to be used for short periods during the day and employs electrical stimulation to (Read more...)
Nystagmus From Living in the Dark Cured With Light Exposure
A new case report of so-called miner’s nystagmus demonstrates the remarkable plasticity of the brain, the authors say, and suggests that historical reports of this condition by miners were genuine. Medscape Medical News
Frozen Sections Can Guide Biopsies for Giant Cell Arteritis
Second TAB procedures are often performed in patients with a high level of suspicion for GCA, which may result in unnecessary treatments and complications, Devon A. Cohen, MD wrote. Medscape Medical News
Samenvatting: Takeda geeft updates over fase 1/2 klinische onderzoeken van Novavax ’en Moderna’s COVID-19-vaccinkandidaten in Japan
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) heeft vandaag aangekondigd dat de eerste proefpersoon werd gedoseerd in zijn fase 1/2 immunogeniteits- en veiligheidsonderzoek van Novavax ‘COVID-19-vaccin kandid…
Global Artificial Cornea and Corneal Implant Market (2021 to 2026) – Shortage of Corneal Donors Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics &…
Sunvera Group Announces New Partnership with Kellis Eye & Laser Center
BINGHAM FARMS, Mich.–(BUSINESS WIRE)–Sunvera Group expands platform into Ohio
Takeda Provides Updates on Phase 1/2 Clinical Trials of Novavax’ and Moderna’s COVID-19 Vaccine Candidates in Japan
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) announced today that the first subject was dosed in its Phase 1/2 immunogenicity and safety study of Novavax’ COVID-19 vaccine candidate (TAK-019) in Japan. Earlie…
Wireless Smart Catheter for Bladder Control: Interview with Matt Monarski, CEO of UroDev Medical
UroDev Medical (formerly Spinal Singularity), a medtech company based in Minneapolis, has developed the IntelliFlow Bladder Management System, a wireless urinary catheter that can be controlled with the touch of a button on a remote control. At present, patients with urinary retention may have to use up to 200 disposable urinary catheters a month. (Read more...)
Researchers identify a neural pathway critical to correcting behavioral errors
Mount Sinai researchers have identified a neural pathway through which the brain detects errors and guides subsequent behavioral improvement. This process, called cognitive control, is frequently dysregulated in a wide range of psychiatric disorders.